Indian pharmaceutical company Cipla has hired former Teva vice-president Frank Pieters as Head of European Business and Head of Global Respiratory Business. Pieters was most recently Senior VP for the Region of Southern Europe at Teva.
Cipla manufactures a wide range of inhaled medications. A recent article in the Business Standard quotes Cipla CFO S Radhakrishnan as saying, “We have a market share of 70 per cent in the inhalation therapy segment in India. Given our technical strengths and expertise in this area, it is imperative for us to leverage these strengths not only in Europe but also in rest of the world.”
Read Economic Times article.
